Document ID: chunk:federal_register_of_legislation:F2020L00213:reg:9:p2
Version: federal_register_of_legislation:F2020L00213
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6812–9932

clinical onset of multiple sclerosis;
            Note: being overweight is defined in the Schedule 1 - Dictionary.
(10)      having type 1 diabetes mellitus before the clinical onset of multiple sclerosis;
(11)      having onset of a viral or bacterial infection within the five weeks before, or the two weeks after, the clinical worsening of multiple sclerosis;
(12)      smoking at least five pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical worsening of multiple sclerosis, and where smoking has ceased, the clinical worsening of multiple sclerosis has occurred within five years of cessation;
Note:  pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.
(13)      being exposed to second-hand smoke for at least 10 000 hours before the clinical worsening of multiple sclerosis;
            Note: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary.
(14)      undergoing a course of treatment with a tumour necrosis factor alpha antagonist within the two years before the clinical worsening of multiple sclerosis;
(15)      undergoing a course of treatment with granulocyte colony-stimulating factor or interferon within the one year before the clinical worsening of multiple sclerosis;
(16)      undergoing a course of treatment with an immune checkpoint inhibitor within the four months before the clinical worsening of multiple sclerosis;
            Note: Immune checkpoint inhibitors include, but are not limited to, ipilimumab, nivolumab, atezolizumab and pembrolizumab.
(17)      experiencing the death of a significant other within the six months before the clinical worsening of multiple sclerosis;
            Note: significant other is defined in the Schedule 1 - Dictionary.
(18)      experiencing a category 1A stressor within the six months before the clinical worsening of multiple sclerosis;
            Note: category 1A stressor is defined in the Schedule 1 - Dictionary.
(19)      experiencing a category 1B stressor within the six months before the clinical worsening of multiple sclerosis;
            Note: category 1B stressor is defined in the Schedule 1 - Dictionary.
(20)      experiencing a category 2 stressor within the six months before the clinical worsening of multiple sclerosis;
             Note 1:  A category 2 stressor can arise in a variety of circumstances connected with service. Such circumstances can arise during the course of service, as a result of separation from service and the conditions associated with that separation, and in the transition to civilian life in the years following separation.
            Note 2:  category 2 stressor is defined in the Schedule 1 - Dictionary.
(21)      having a medical illness or injury, other than multiple sclerosis, which is life-threatening or which results in serious physical or cognitive disability, within the six months before the clinical worsening of multiple sclerosis;
(22)      for women only, using hormonal assisted reproductive therapy within the three months before the